This article was originally published in SRA
US FDA draft guidance on NSAIDs for use in animals
You may also be interested in...
Bayer notes “significant headwinds" from pandemic hitting its 2020 results likely will continue in 2021, when it t expects core earnings per share slightly below 2020 levels. While noting slumping revenues across its divisions, Bayer said an exception its consumer health business.
After US President Trump said vaccine developers could develop a COVID-19 vaccine faster if it weren't for politics, Moderna CEO Bancel said no political party has asked the company to move faster or slower.
The US green light for Alkindi is a big step for the UK biotech in its bid to become a world-leading specialty endocrinology business.